VitalCare's "Patient Of The Month" Program Launch : Former Hunter-Killer Team Commander of 101st Airborne "Screaming Eagles" Testimony
VitalCare Diabetes Treatment Centers, Inc. (Pinks Sheets: VDTI), today announces the first personal testimony about iCAT Therapy on the Company’s website under the section titled, “Patient of the Month”.
CARSON CITY, Nev. (PRWEB) June 19, 2008
"We are very excited to have an opportunity to share the personal testimonies from patients who are currently receiving iCAT Therapy or who have received iCAT therapy and would like to share their experience with us," says Jimmy A. McDougald, CEO and Co-founder of VitalCare.
Learn how this former US Army Helicopter "Hunter-Killer" Team Commander of the 101st Airborne "Screaming Eagles" was medically discharged from the US Army due to his undiagnosed diabetes. Read his personal testimony, how this US Army officer was grounded by diabetes, effectively ending his military career, how he began to suffer secondary complications from the Type 2 diabetes and how he finally recovered. Get his full story by logging into the VitalCare website at www. vitalcaretechnology. com and follow the link to "Patient of the Month".
In an effort to provide a resource for those seeking to better determine if iCAT Therapy is a treatment option and to find out where the closest iCAT Therapy provider is, VitalCare will continually update its website as a means of providing information, for both healthcare providers and those with Type 1 or Type 2 diabetes.
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on the emerging and FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as "Intracellular Activation Therapy (iCAT)." The World Health Organization (WHO) estimates that more than 180 million people worldwide have diabetes. According to the WHO, this number is likely to more than double by 2030 with diabetes related deaths projected to increase by more than 50% in the next 10 years without urgent action. The US Center for Disease Control, 2005 National Diabetes Fact Sheet, reports the total prevalence of Diabetes in the US for all ages is 20.8 million of which 14.6 million are diagnosed and 6.2 million are undiagnosed.
Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.'s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.'s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare's filings with the Securities and Exchange Commission.
